Entering edit mode
                    10.2 years ago
        andrew
        
    
        ▴
    
    560
    I found this site on Thomson Reuters about a consortium for Computational Biology for Drug Discovery and it's a bit obscure. I've contacted them but I think they are solely focused on big pharma. Does anyone have any additional information on this group and what things they are curating? I see they have a Phase 5, but no information about what that means.